A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results

被引：0

作者：

Lampertico, Pietro ^{[1
]}

Buti, Maria ^{[2
]}

Ramji, Alnoor ^{[3
]}

Fung, Scott ^{[4
]}

Ahn, Sang Hoon ^{[5
]}

Chuang, Wan-Long ^{[6
]}

Yoon, Seung Kew ^{[7
]}

Kao, Jia-Horng ^{[8
]}

Chen, Chi-Yi ^{[9
]}

Tam, Edward ^{[10
]}

Khalili, Mandana ^{[11
]}

Bae, Ho ^{[12
]}

Ma, Xiaoli ^{[13
]}

Tak, Won Young ^{[14
]}

Flaherty, John F. ^{[15
]}

Gaggar, Anuj ^{[15
]}

Suri, Vithika ^{[15
]}

Tan, Susanna ^{[15
]}

Liu, Yang ^{[15
]}

Wu, George ^{[15
]}

Subramanian, Mani ^{[15
]}

Hann, Hie-Won ^{[16
]}

Agarwal, Kosh ^{[17
]}

Lim, Young-Suk ^{[18
,19
]}

Chan, Henry ^{[19
,20
]}

机构：

[1] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[2] Hosp Gen Univ Valle Hebron & Ciberehd, Barcelona, Spain

[3] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada

[4] Toronto Gen Hosp, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada

[5] Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea

[6] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[7] Catholic Univ Korea, Dept Internal Med, Seoul, South Korea

[8] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan

[9] Chia Yi Christian Hosp, Chiayi, Taiwan

[10] LAIR Ctr, Vancouver, BC, Canada

[11] Univ Calif San Francisco, San Francisco, CA 94143 USA

[12] St Vincents Med Ctr, Los Angeles, CA USA

[13] Drexel Univ, Coll Med, Philadelphia, PA USA

[14] Kyungpook Natl Univ, Coll Med, Daegu, South Korea

[15] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[16] Thomas Jefferson Univ Hosp, Div Gastroenterol & Hepatol, Philadelphia, PA USA

[17] Kings Coll Hosp London, Inst Liver Studies, London, England

[18] Univ Ulsan, Ctr Liver, Asan Med Ctr, Dept Gastroenterol,Coll Med, Ulsan, South Korea

[19] Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, Hong Kong, Peoples R China

[20] Chinese Univ Hong Kong, Dept Med & Therapeut, State Key Lab Digest Dis, Hong Kong, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

AS091

引用

页码：S67 / S68

页数：2

共 50 条

[1] A PHASE 3 STUDY COMPARING SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) WITH CONTINUED TDF TREATMENT IN VIROLOGICALLY-SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B (CHB): WEEK 48 EFFICACY AND SAFETY RESULTS
Chan, Henry Lik Yuen
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John
Gaggar, Anuj
Lau, Audrey
Feierbach, Becket
Wu, George
Suri, Vithika
Subramanian, Mani
Huy Trinh
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
GUT, 2019, 68 : A142 - A143
[2] A Phase 3 Study Comparing Switching: Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) With Continued TDF Treatment in Virologically Suppressed Patients With Chronic Hepatitis B: Final Week 96 Results
Khalili, Mandana
Lampertico, Pietro
Bae, Ho S.
Ma, Xiaoli
Ramji, Alnoor
Fung, Scott
Ahn, Sang Hoon
Kao, Jia-Horng
Tam, Edward
Halton, Patricia
Yee, Leland
Flaherty, John
Gaggar, Anuj
Liu, Yang
Wu, George
Hann, Hie-Won
Agarwal, Kosh
Lim, Young-Suk
Buti, Maria
Chan, Henry
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S543 - S543
[3] A phase 3 study comparing switching from tenofovir disoproxil fumarate to tenofovir alafenamide with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Ramji, Alnoor
Tak, Won Young
Chen, Chiyi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John F.
Gaggar, Anuj
Lau, Audrey
Feierbach, Becket
Wu, George
Suri, Vithika
Subramanian, Mani
Trinh, Huy N.
Yoon, Seung Kew
Agarwal, Kosh
Lim, Young-Suk
Chan, Henry
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E470 - E471
[4] EFFICACY AND SAFETY RESULTS 48 WEEKS AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) VS CONTINUED TDF TREATMENT IN VIROLOGICALLY-SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John F.
Gaggar, Anuj
Lau, Audrey H.
Feierbach, Becket
Wu, George
Suri, Vithika
Subramanian, Mani
Trinh, Huy N.
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
Chan, Henry L.
GASTROENTEROLOGY, 2019, 156 (06) : S1195 - S1195
[5] A Phase 3 Study Comparing Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide With Continued TDF Treatment in Virologically Suppressed Patients With Chronic Hepatitis B: Week 48 Efficacy and Safety Results
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John F.
Gaggar, Anuj
Lau, Audrey
Feierbach, Becket
Wu, George
Suri, Vithika
Subramanian, G. Mani
Oberle, Corinna
Huy Trinh
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
Chan, Henry L. Y.
SWISS MEDICAL WEEKLY, 2019, : 25S - 25S
[6] 96-WEEK EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) SWITCH VS. CONTINUED TDF TREATMENT AMONG VIROLOGICALLY-SUPPRESSED HEPATITIS B PATIENTS OF ASIAN ETHNICITY
Ahn, Sang Hoon
Kao, Jia-Horng
Lampertico, Pietro
Ramji, Alnoor
Fung, Scott
Chuang, Wan-Long
Kim, Yoon Jun
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Lee, June Sung
Chan, Carol Yee Kwan
Yee, Leland J.
Sethi, Shalini
Flaherty, John
Zhao, Yang
Gaggar, Anuj
Hann, Hie Won
Lim, Young-Suk
Chan, Henry Lik Yuen
GUT, 2021, 70 : A77 - A78
[7] A phase 3 study comparing tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive, chronic hepatitis B (CHB): efficacy and safety results at week 96
Agarwal, K.
Fung, S.
Seto, W. K.
Lim, Y. S.
Gane, E.
Janssen, H. L.
Sharma, M.
Chuang, W. L.
Bae, H.
Yoon, K. T.
Flaherty, J. F.
Lau, A.
Gaggar, A.
Suri, V.
Cathcart, A.
Lin, L.
Subramanian, G. M.
Shalimar
Furusyo, N.
Buti, M.
Chan, H. L.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S478 - S478
[8] Week 96 Efficacy and Safety of Tenofovir Alafenamide (TAF) versus Tenofovir Disoproxil Fumarate (TDF) in Older, HIV-Infected Virologically-Suppressed Adults
Goldstein, D.
Ward, D.
Brinson, C.
Crofoot, G.
Ryu, J.
Haubrich, R.
Sparrow, T. L.
McCallister, S.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S48 - S48
[9] WEEK 96 EFFICACY AND SAFETY RESULTS OF TENOFOVIR ALAFENAMIDE (TAF) COMPARING TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B (CHB), HBEAG-POSITIVE PATIENTS: A GLOBAL PHASE 3 STUDY
Agarwal, Kosh
Fung, Scott
Seto, Wai-Kay
Lim, Young-Suk
Gane, Edward
Janssen, Harry L.
Chuang, Wan-Long
Bae, Ho
Yoon, Ki Tae
Flaherty, John F.
Lau, Audrey
Gaggar, Anuj
Suri, Vithika
Cathcart, Andrea
Lin, Lanjia
Chan, Alain
Shalimar, Mani Subramanian
Furusyo, Norihiro
Buti, Maria
Chan, Henry L.
GASTROENTEROLOGY, 2017, 152 (05) : S1085 - S1086
[10] WEEK 96 EFFICACY AND SAFETY RESULTS OF TENOFOVIR ALAFENAMIDE (TAF) COMPARING TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B (CHB), HBEAG-NEGATIVE, CHRONIC HEPATITIS B PATIENTS: A GLOBAL PHASE 3 STUDY
Brunetto, Maurizia Rossana
Lim, Young-Suk
Gane, Edward
Seto, Wai-Kay
Osipenko, Marina
Ahn, Sang Hoon
Janssen, Harry L.
Shukla, Akash
Chuang, Wan-Long
Trinh, Huy N.
Celen, Mustafa
Flaherty, John F.
Chan, Alain
Lau, Audrey
Gaggar, Anuj
Suri, Vithika
Subramanian, Mani
Pan, Calvin Q.
Izumi, Namiki
Marcellin, Patrick
Chan, Henry L.
Buti, Maria
GASTROENTEROLOGY, 2017, 152 (05) : S1086 - S1086

← 1 2 3 4 5 →